Roche and AstraZeneca Join the RNAi Race
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 86 (Table of Contents)
Published: 1 Aug-2007
DOI: 10.3833/pdr.v2007.i86.303 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
The potential to deliver both life-saving and financially lucrative medicines has put RNA interference (RNAi) on the must-have lists of major pharmas...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS